Amy Spallone, M.D.

University of Texas MD Anderson Cancer Center

Disclosure(s): No financial relationships to disclose

Poster(s):

• 544 - PICKUP: Pneumonia in the Immunocompromised - Use of the Karius Test for Detection of Undiagnosed Pathogens
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1209 - The Impact of the COVID-19 Pandemic on Hospital-Acquired Infections at a Comprehensive Cancer Center
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 1914 - Characteristics of Hospital Onset SARS Cov-2 Infections Before and After the Emergence of The Highly Transmissible Variant B.1.1.529 In a Comprehensive Cancer Center
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2119 - Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2121 - The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2122 - The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET